Community/Retail

As smart infusion technology is increasingly used by pharmacists in health-system settings, analyzing data from these devices can prove key to improving patient health.

The American Society of Health-System Pharmacists (ASHP) recognized its Donald Francke Medal recipient and other award winners at the 2018 ASHP Midyear Clinical Meeting in Anaheim, CA.

Safety data came from both phase 3 studies as well as a phase 2 study of Dextenza, which together totaled 351 patients.

The 2018 ASHP Midyear Clinical Meeting got off to a magical start today when basketball legend, businessman, and HIV/AIDS advocate Earvin “Magic” Johnson delivered the keynote address at the convention’s opening session, drawing upon his experiences, both on the basketball court and in the business world, to empower attendees to embrace their potential as health care providers and leaders.

In this clip, Mark Eastham, RPh, the senior vice president and general manager of McKesson RxO, discusses recent trends in health care delivery.

The research, a part of AmerisourceBergen’s first-ever Pharmacy Check-Up: Activity & Barriers to Care Analysis, examined various pharmacy settings.

Flu levels are typically at their highest between December and February.

In a satellite symposium at the 2018 American Society of Health-Systems Pharmacists (ASHP) Midyear Clinical Meeting in Anaheim, CA, the increasing rate of drug shortages was discussed, along with best practices pharmacists can use to mitigate the ongoing issue.

Rural areas are prone to unique health care challenges that are being met with policy changes and innovation.

Can you solve the pharmaceutical mystery? Each week, a new case study is presented.

Brock Slabach, MPH, FACHE, Senior Vice-President of the National Rural Health Association, discussed new developments in rural health care at the American Society of Health-System Pharmacists (ASHP) Midyear 2018 Clinical Meeting in Anahein, CA. In this clip, he discusses how Congress might support rural health care in 2019.

While scientists know more about the HIV infection than ever, and can prevent it from progressing into AIDS, there is still no known cure for the virus.

It might seem a bit odd to discuss ASHP Midyear before the holidays, but it’s never too soon to start looking ahead.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

ASHP’s 2018 Midyear Clinical Meeting is set to begin, and Pharmacy Times will be on site covering it.

Recommendations for how to address the issue have not been limited to the panel discussions.

The American Society of Health-Systems Pharmacists 2018 Midyear Clinical Meeting is right around the corner, and Pharmacy Times will be on site in Anaheim, CA to cover the conference.

Immunotherapy was first linked to cancer treatment in the late 19th century when surgeon William Coley discovered that the injection of bacteria into sarcoma sites led to tumor shrinkage.

Amifampridine (Firdapse) is a first-in-class therapy for Lambert-Eaton myasthenic syndrome, a rare autoimmune disorder.

Your residency cover letter might be the most challenging part of the whole application process.

The drug’s application was designated for fast track and priority review, as well as orphan product status.

Rituximab-abbs (Truxima, Celltrion) is the fifteenth biosimilar approved by the FDA and the sixth biosimilar approved in 2018, thus far.

CVS Health announced that it has closed its acquisition of Aetna with the promise to transform the consumer health experience.

Teva Pharmaceuticals has initiated a voluntary recall in the United States, to the patient level, of all lots of Amlodipine/Valsartan combination tablets and Amlodipine Valsartan/Hydrochlorothiazide combination tablets, due to an impurity detected above specification limits in an active pharmaceutical ingredient (API) manufactured by Mylan India.

The Task Force notes in the draft recommendations that clinicians should screen everyone between the ages 15 to 65 years and all pregnant women for HIV.

Purdue University researchers have developed a shoe insole that could help make the healing process more portable for the 15% of Americans who develop ulcers as a result of diabetes.

The FDA has granted an accelerated approval to larotrectinib (Vitrakvi, Loxo Oncology) for the treatment of adult and pediatric patients with solid tumors that have an NTRKgene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity, and have no satisfactory alternative treatments or that have progressed following treatment.

The single-dose, prefilled autoinjector for tocilizumab (Actemra) offers an additional option for patients with rheumatoid arthritis, giant cell arteritis, and 2 forms of juvenile arthritis.

FDA officials cited the possibility of a cardiovascular (CV) safety risk based on Zafgen's prior compound and outlined potential paths for moving forward.

More than 160 patients have thus far been treated with investigational therapeutics under an ethical framework developed by WHO.